Project Grant K23DA063870
- This Project Grant award, titled "PROJECT DEDUCE: DIGITAL ENVIROTYPING TO DEVELOP UNDERSTANDING OF CIGARETTE SMOKING AND THE ENVIRONMENT", is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to leverage computer vision and digital tools to accurately characterize the environments of people who smoke, with the goal of identifying environmental markers of smoking behavior and relapse risk. The...
- This $105,076 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the neurocomputational basis of effort-based decision making (EBDM) in individuals with tobacco use disorder, tobacco and opioid use disorder, and healthy controls. The award will support research to characterize the neurocomputational basis of EBDM during a smoking cessation attempt. The project will computationally model...
- The federal Project Grant award titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit" is funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $663,554.00 with an award date of August 18, 2025 and an ultimate completion date of July 31, 2030. The grant supports research to explore the use of harm reduction product sampling, such as e-cigarettes, heated tobacco products, and oral...
- This federal Project Grant award, in the amount of $798,473, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research to develop and evaluate a brief, web-based intervention called Regulation of Craving Training (ROC-T) for smoking cessation. The project aims to test two versions of ROC-T - one focused on reappraisal skills and one on mindfulness-based acceptance - as a preparation intervention to be...
- This $139,457 Project Grant award, issued by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs), supports a research project at the University of Oklahoma Health Sciences Center (OUHSC). The project aims to: Evaluate the role of depressive symptoms on smoking cessation and treatment mechanisms using a Just-In-Time Adaptive Intervention (JITAI) approach. This will examine how treatment mechanisms vary between adults with and without elevated depressive...
- This $325,734 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund the development, evaluation, and dissemination of "STATWISEAI" - an AI-powered educational tool to enhance methodological rigor in analyzing complex, large-scale datasets for biomedical and behavioral research. The key products and services to be delivered through this 3-year award (9/15/2025 - 8/31/2028) include: 1)...
- This federal Project Grant award, funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research), is focused on developing a cue-based smoking cessation intervention delivered via telehealth for people who smoke lightly (PSLI). The $906,306 award, with a performance period from September 2025 to August 2028, aims to adapt and pilot test an intervention that combines cue-based treatment with standard cognitive behavioral therapy (CBT) to promote smoking cessation...
- This $693,491 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a mixed methods study to advance the scientific understanding of nicotine pouch use among U.S. adults. The study will employ a nationally representative longitudinal survey integrated with qualitative interviews to investigate who is using nicotine pouches, their reasons for use, methods, frequency, and intensity of use, as well as...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multi-method study on momentary distress intolerance and its relationship to cigarette smoking among adults with emotional distress. The $233,913 award to Rutgers, The State University will fund a 5-year research plan involving qualitative investigation, ecological momentary assessment, and longitudinal modeling to better understand...
- This federal Project Grant award of $164,484.00 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports the development and evaluation of smoking cessation messages targeted to adults who smoke nondaily. The project, conducted by the University of Kentucky Research Foundation, aims to create tailored communications that increase knowledge, worry, risk perceptions, motivation, and intentions to quit smoking among this population. The researchers will...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to develop machine learning approaches to personalize cigarette smoking risk prediction for adults trying to quit smoking. The $200,676 award supports research to identify dynamic patterns and key features that predict smoking lapses and relapses during quit attempts, in order to inform the development of personalized smoking cessation interventions and clinical decision support tools. The 5-year project, starting on Sep 1, 2025, will be conducted by researchers at the University of Wisconsin-Madison, which has demonstrated extensive expertise in federal research grants across various scientific and technological domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $200.7k | 8/21/25 |